The long-term goal of our research program is to study the genetic regulation of proteins, which play a critical role in cardiac physiology. In particular, our studies focus on proteins of contractile apparatus and ion transport pumps. Since the primary step in the control of protein synthesis occurs at the level of transcription, the proposed studies will involve the detailed analysis of cis-DNA elements and transacting factors controlling gene expression. In this proposal, we will focus our attention on two cardiac muscle genes: 1) sarcoplasmic reticulum (SR) Ca2' ATPase, and 2) the ventricular myosin light chain (MLC1V). Specific-ally our goals are to focus our analysis on tissue specific regulation and to examine those involved in altering gene expression during adaptive growth resulting from pressure overload and thyroxine administration. To dissect the various regulatory elements, we will use in vitro cell culture models (cardiocytes and muscle cell lines); and in particular, we propose to use P19 embryonal carcinoma cells which have the potential to differentiate into cardiac cells. Once the cis-regulatory elements are identified, we will use them to characterize nuclear- regulatory proteins that interact with them. The final and long-term goal of this project is to develop methods to isolate CDNA clones/gene for the cardiac muscle specific regulatory proteins, and perform structure-function analysis of these molecules. Thus the overall emphasis of this proposal is to study and understand in detail how the control of transcription operates in cardiac muscle.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL028001-12
Application #
3780232
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
12
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Vermont & St Agric College
Department
Type
DUNS #
066811191
City
Burlington
State
VT
Country
United States
Zip Code
05405
Peterson, J N; Nassar, R; Anderson, P A et al. (2001) Altered cross-bridge characteristics following haemodynamic overload in rabbit hearts expressing V3 myosin. J Physiol 536:569-82
Peterson, J N; Alpert, N R (1998) Cross-bridge dynamics in the contracting heart. Adv Exp Med Biol 453:117-23;discussion 123-4
Alpert, N R; Mulieri, L A (1997) Human heart failure: determinants of ventricular dysfunction. Adv Exp Med Biol 430:97-108
Peterson, J N; Alpert, N R (1996) Molecular motor mechanics in the contracting heart. V1 versus V3 myosin heavy chain. Ann N Y Acad Sci 793:54-63
VanBuren, P; Harris, D E; Alpert, N R et al. (1995) Cardiac V1 and V3 myosins differ in their hydrolytic and mechanical activities in vitro. Circ Res 77:439-44
Haeberle, J R (1994) Calponin decreases the rate of cross-bridge cycling and increases maximum force production by smooth muscle myosin in an in vitro motility assay. J Biol Chem 269:12424-31
Zarain-Herzberg, A; Marques, J; Sukovich, D et al. (1994) Thyroid hormone receptor modulates the expression of the rabbit cardiac sarco (endo) plasmic reticulum Ca(2+)-ATPase gene. J Biol Chem 269:1460-7
Laporte, R; Haeberle, J R; Laher, I (1994) Phorbol ester-induced potentiation of myogenic tone is not associated with increases in Ca2+ influx, myoplasmic free Ca2+ concentration, or 20-kDa myosin light chain phosphorylation. J Mol Cell Cardiol 26:297-302
Hemric, M E; Tracy, P B; Haeberle, J R (1994) Caldesmon enhances the binding of myosin to the cytoskeleton during platelet activation. J Biol Chem 269:4125-8
Fisher, S A; Periasamy, M (1994) Collagen synthesis inhibitors disrupt embryonic cardiocyte myofibrillogenesis and alter the expression of cardiac specific genes in vitro. J Mol Cell Cardiol 26:721-31

Showing the most recent 10 out of 32 publications